The FDA approved pembrolizumab in combination with paclitaxel, with or without bevacizumab, for adult patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal carcinoma whose tumors express PD-L1 (CPS ≥1).
The FDA approved multiple denosumab biosimilars in late 2025 and issued REMS safety updates emphasizing severe hypocalcemia risk in patients with advanced chronic kidney disease, including reported hospitalizations and fatalities.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07428057 |
Postoperative Hypocalcemia After Thyroidectomy |
RECRUITING | |
| NCT07416149 |
Comparing PTeye-assisted Versus Conventional Total Thyroidectomy |
RECRUITING | NA |
| NCT07043010 |
WHITE CAP: Intra-operative Parathyroid Tissue Sensor (PTS)-Guided Assessment of Parathyroid Viability and Surgical Decision-Making |
NOT_YET_RECRUITING | NA |
| NCT06820645 |
Calcium Administration in Life-saving Management During Massive Hemorrhage |
NOT_YET_RECRUITING | PHASE2/PHASE3 |
| NCT06775288 |
Hypoglycemia Prevention and Awareness Program |
ACTIVE_NOT_RECRUITING | NA |
| NCT06763549 |
COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG Wearable |
ENROLLING_BY_INVITATION | |
| NCT06716632 |
A Comparative Analysis of Hypocalcemia Incidence in Patients Undergoing Thyroidectomy: Ligasure vs Conventional Ligation of Vessels by Knot Tying |
COMPLETED | NA |
| NCT05973747 |
Pharmacokinetic Equivalence of Calcium Gluconate and Calcium Chloride in Parturients |
COMPLETED | EARLY_PHASE1 |
| NCT05953376 |
Empiric Calcium in Massive Transfusion |
WITHDRAWN | PHASE3 |
| NCT05885256 |
Clinical Assessment of Low Calcium In traUMa (CALCIUM) |
ACTIVE_NOT_RECRUITING |
